GBT (GTCH) Technologies Looking for Strategic Partners.

GBT Has Opened the Doors for Massive Potential in Minimal Infrastructure Communications. There are some Artificial Intelligence rocket-scientists...

Citius Pharma (CTXR) $2.15. Price Target of $8.00 Maintained, Post Safety and Efficacy Review.

Investment Banker Buy Rating Maintained: DSMB Gives the Thumbs Up – Data in Early 2022. CITIUS NEWS ARCHIVE
@bryteeyes3

Citius (CTXR). Dang Flippers!

Short term investors powered Citius from $2.50 to near $4.50 in hopes of a positive early trial...
Marijuana Stock Review, urban-gro

urban-gro (UGRO) $10.15 Marijuana’s First Fully Integrated Indoor Cultivation Powerhouse.

urban-gro announces its first major acquisition since raising $62 million in February and it's a doozey! The inclusion of architecture allows them...
Drone Stock Review

10 Best Drone Stocks to Invest In (InsiderMonkey).

In this article, we will look at the 10 best drone stocks to invest in based on the data of over 860...
Hea;thLynked, Biotech Stock Review

Up 191%, HealthLynked (HLYK) Reporting Decent Numbers.

Up as much as 417% from where we added it to the Watch List, the Company continues to report increasing revenues while...

Aphex BioCleanse (SNST) Making Serious Headlines.

Relatively quiet for most of the year. Aphex BioCleanse, our favorite Super Bug sanitizer company, made two back-to-back announcements - signaling things...

Draganfly (DFLYF) to Deploy Aerial Sanitation Drones Over NASCAR Event.

Nashville Superspeedway Selects Draganfly Drone Services for June 18-20 NASCAR Weekend Los Angeles,...
Danny Ritman

GBT Technologies (GTCH) Aims to Power Wearable GPS Tracker for Seniors.

GOPHER | GBT TECNOLOGIES https://youtu.be/9ovYCMHmOi8 GBT Technologies and GTX Corp. Enter into...
@NCI

Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in Stem Cell and...

- Addition of leading scholar and KOL in acute respiratory distress syndrome (ARDS) to ARDS Scientific Advisory Board supports continued progress of...

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...